Cargando…
Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery
Despite many articles regarding the antihemorrhagic treatment and prophylaxis, there is a lack of experience about how to best conduct major surgical procedures in patients with congenital factor XIII (FXIII) deficiency. Here we report a case of surgery (right inguinal hernia, complicated by heavine...
Autores principales: | Sottilotta, Gianluca, Luise, Francesca, Oriana, Vincenzo, Piromalli, Angela, Santacroce, Rosa, Di Lelio, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397991/ https://www.ncbi.nlm.nih.gov/pubmed/30915205 http://dx.doi.org/10.4081/hr.2019.7912 |
Ejemplares similares
-
Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?
por: Korte, Wolfgang
Publicado: (2014) -
Efficacy of Octocog Alfa (Advate) in a Child with Type 3 von Willebrand Disease and Alloantibodies
por: Sottilotta, Gianluca, et al.
Publicado: (2017) -
Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment
por: Sottilotta, Gianluca, et al.
Publicado: (2021) -
Treatment with Recombinant Factor XIII (Tretten) in a Pregnant Woman with Factor XIII Deficiency
por: Abdel-Samad, Nizar
Publicado: (2017) -
Hemorrhagic Shock after Neonatal Circumcision: Severe Congenital Factor XIII Deficiency
por: Cohen, Erin L., et al.
Publicado: (2021)